$138m matches up pretty well with Symphony Rx #s for Q1. So I wonder what happened to those 1000+ Rxs before Jan 15 ABBV management was chirping about... Surprising ex-US #s.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.